EUCTR2005-002982-35-GB进行中（未招募）1 期
The effect of Niaspan (slow release nicotinic acid) on plasma phosphate, and renal phosphate handling in patents with severe chronic kidney disease - Niaspan in CKD
Barts and The London NHS Trust0 个研究点目标入组 0 人开始时间: 2005年8月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with CKD stages 4-5
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients unable to give informed consent.
- •Patients under the age of 18 years
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the effect of NICOtinic acid (niacin) on elevated Lipoprotein(a) levels (NICOLa Study) - NICOLaipoprotein (Lp)(a) has been associated with an increased risk of coronary heart disease, cerebrovascular disease, and peripheral arterial vascular disease. Potential therapies to reduce elevated Lp(a) levels include nicotinic acid (niacin), but there is a lack of randomised controlled studies assessing the effectiveness of these therapies in lowering Lp(a) as a primary endpoint and in reducing cardiovascular events in the long term.EUCTR2006-005710-12-DECharité Universitätsmedizin Berlin150
尚未招募
4 期
Abnormal serum triglyceride(form of fat)& low HDL cholesterol, important risk factors for heart & blood vessel diseases. Niacin, lipid lowering drug, is less used due to its side effects, can be minimized by adding Laropiprant. We study the drugs effect on both serum triglyceride & low HDL levelsCTRI/2011/08/001977Sub arm study of PURSE HIS funded by Department of Science and Technology Government of India50
招募中
Unknown
Evaluation of the effects of nicotineamide mononucleotide administered intravenously to healthy subjects.healthy subjectsJPRN-UMIN000049123TOKYO GINZA WELLNESS & AGING CLINIC20
尚未招募
3 期
icotinic Acid and Lipoprotein (a): The Effect of Extended Release Nicotinic Acid on Plasma Lipoprotein (a), its Isoforms and apo(a) FragmentsCardiovascular - Coronary heart diseaseHyperlipidemiaACTRN12611000252910A/Prof. K.Kostner30
已完成
不适用
Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed DyslipidemiaInsulin SensitivityLipoproteins MetabolismNon Esterified Fatty Acid KineticsLipid ProfileNCT01216956Centre de Recherche en Nutrition Humaine Rhone-Alpe24